US Patent 10889631 Therapeutic variant alpha-2-macroglobulin compositions
Patent 10889631 was granted and assigned to Cytonics Corporation on January, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10889631 Therapeutic variant alpha-2-macroglobulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
